Connect with us

Hi, what are you looking for?

Jewish Business News

World News

Chinese coronavirus vaccine shot triggered an antibody response in more than 90% of patients

Phase I tested safety, with none of the participants reporting any severe side effects from the vaccine.The company to begin Phase III trials the last step before it is approved for public use

Sinovac Biotech Ltd. based in Beijing, China, said its vaccine called CoronaVac found safe and positive early data from human trials, Sinovac said in a press release on Sunday.

More than 90% of people who received the vaccine have induced neutralizing antibodies two weeks after inoculation. The shot hasn’t caused severe side effects.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

The trial was randomized, double-blind, and placebo-controlled. 743 healthy people between ages 18 to 59 have participated in the trial conducted at the Jiangsu Provincial Center for Disease Control and Prevention, Eastern China.

Out of 743 participants, 143 are included in Phase I, testing the safety of the immunization, which is a dead strain of the virus.

All others are in Phase II, seeing if antibodies would be triggered after being given two shots in 14 days.

The company says another group in the study will be given the shots on a 28-day interval to see if that is more effective.

The company also announced earlier this month a partnership with company Instituto Butantan to conduct its phase III trial in Brazil. The South American country has become the second-largest outbreak of COVID-19  in a global pandemic that so far infected more than 7.7 million people and killed over 428,000.




You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.